Prophylactic application of modified vacuum-assisted closure therapy in Ivor Lewis esophagectomy: Preliminary results

doi:10.4240/wjgs.124340

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 11

This Article

(0)

(45)

Peer-Review Report of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Surg. Nov 27, 2026; 18(11): 124340
Published online Nov 27, 2026. doi: 10.4240/wjgs.124340

Table 1 Patient demographics and baseline characteristics, n (%)

	Total (n = 31)	ModVAC (n = 16)	No-ModVAC (n = 15)	P value
Sex
Male	19 (64.5)	10 (62.5)	10 (66.7)
Female	11 (35.5)	6 (37.5)	5 (33.3)	0.80¹
Age (mean)	59	61	57	0.33²
Comorbidities
DM	7 (23.3)	5 (33.3)	2 (13.3)	0.19¹
CAD	7 (23.3)	3 (20)	4 (26.7)	0.66¹
Smoking	21 (70)	10 (66.7)	11 (73.3)	0.69¹
ASA score
2	26 (83.8)	14 (87.5)	12 (80)
3	5 (16.2)	2 (12.5)	3 (20)	0.59³
Pathology
Adenocarcinoma	15 (48.4)	9 (56.3)	6 (40)
SCC	14 (45.2)	6 (37.5)	8 (53.3)
Benign	2 (6.5)	1 (6.3)	1 (6.7)	0.65¹
Tumor location
Middle	2 (6.5)	0	2 (13.3)
Distal	21 (67.7)	11 (68.6)	10 (66.7)
GEJ	8 (25.8)	5 (31.3)	3 (20)	0.22¹
Neoadjuvant therapy
No	12 (38.7)	5 (31.3)	7 (46.7)
Yes	19 (61.3)	11 (68.8)	8 (53.3)	0.37¹

¹χ².

²T-test.

³Mann-Whitney U test.

ASA: American Society of Anesthesiologists; CAD: Coronary artery disease; DM: Diabetes mellitus; GEJ: Gastroesophageal junction; ModVAC: Modified, endoscopy-independent prophylactic vacuum-assisted closure system; SCC: Squamous cell carcinoma.

Full Size Table

Table 2 Modified, endoscopy-independent prophylactic vacuum-assisted closure system application parameters

	Maximum	Minimum	Mean
Aspirated fluid, mL	1800	0	489
Duration of application, days	11	2	4.3
Length of hospital stay, days	56	7	20.4

Full Size Table

Table 3 Surgical approach and clinical outcomes in modified, endoscopy-independent prophylactic vacuum-assisted closure vs non-modified, endoscopy-independent prophylactic vacuum-assisted closure patients, n (%)

	Total (n = 31)	ModVAC (n = 16)	No-ModVAC (n = 15)	P value
Operation type
Minimally invasive	8 (25.8)	7 (43.8)	1 (6.7)
Open	13 (41.9)	3 (18.8)	10 (66.7)
Hybrid	10 (32.3)	6 (37.5)	4 (26.7)	0.01¹
Anastomosis
Linear stapler	12 (38.7)	6 (37.5)	6 (40)
Circular stapler	14 (45.2)	10 (62.5)	4 (26.7)
Hand sewn	5 (16.1)	0	5 (33.3)	0.02¹
Jejunostomy	15 (48.4)	8 (50)	7 (46.7)	0.85¹
Postoperative length of stay (mean days)	20.8	20.4	21.3	0.88²
Anastomotic leak
Absent	21 (67.7)	12 (75)	9 (60)
Present	10 (32.3)	4 (25)	6 (40)	0.37¹
Clavien-Dindo
Grade I-IIIa	10 (62.5)	6 (66.7)	4 (57.1)
Grade IIIb-IV	6 (37.5)	3 (33.3)	3 (42.9)	0.69¹

¹χ².

²T-test.

ModVAC: Modified, endoscopy-independent prophylactic vacuum-assisted closure system.

Full Size Table

Citation: Ciciboga K, Uprak TK, Ermerak NO. Prophylactic application of modified vacuum-assisted closure therapy in Ivor Lewis esophagectomy: Preliminary results. World J Gastrointest Surg 2026; 18(11): 124340
URL: https://www.wjgnet.com/1948-9366/full/v18/i11/124340.htm
DOI: https://dx.doi.org/10.4240/wjgs.124340

Ciciboga K, Uprak TK, Ermerak NO. Prophylactic application of modified vacuum-assisted closure therapy in Ivor Lewis esophagectomy: Preliminary results. World J Gastrointest Surg 2026; 18(11): 124340 [DOI: 10.4240/wjgs.124340]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.